tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Creative Medical Technology price target lowered to $26 from $30 at Roth MKM
PremiumThe FlyCreative Medical Technology price target lowered to $26 from $30 at Roth MKM
5M ago
Creative Medical secures FDA clearance for dose escalation in Phase 1/2 trial
Premium
The Fly
Creative Medical secures FDA clearance for dose escalation in Phase 1/2 trial
5M ago
Creative Medical Technology Approves Executive Bonuses
Premium
Company Announcements
Creative Medical Technology Approves Executive Bonuses
5M ago
Creative Medical Technology expands collaboration with Greenstone Biosciences
PremiumThe FlyCreative Medical Technology expands collaboration with Greenstone Biosciences
6M ago
Creative Medical reports data from first cohort in Phase 1/2 CELZ-201-DDT trial
Premium
The Fly
Creative Medical reports data from first cohort in Phase 1/2 CELZ-201-DDT trial
6M ago
Creative Medical advances FDA cleared ADAPT trial with independent review
Premium
The Fly
Creative Medical advances FDA cleared ADAPT trial with independent review
9M ago
Creative Medical CEO: ‘momentum’ towards commercialization ‘continuing to build’
PremiumThe FlyCreative Medical CEO: ‘momentum’ towards commercialization ‘continuing to build’
1y ago
Creative Medical Technology announces development of IPSCelz program
Premium
The Fly
Creative Medical Technology announces development of IPSCelz program
1y ago
Creative Medical gets FDA authorization for CELZ-201 expanded access therapy
Premium
The Fly
Creative Medical gets FDA authorization for CELZ-201 expanded access therapy
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100